FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
Revance Therapeutics (NASDAQ: RVNC) reported Q1 EPS of ($1.15), $0.25 worse than the analyst estimate of ($0.90).
First of all, I would like to sincerely thank all of those who are currently... More

